Clarus Ventures Wants To Pick Up The Tab For Big Pharma's R&D With New $910 Million Fund Post author:Sam Post published:July 17, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Agile Therapeutics, Inc. Announces A Poster Presentation Of Its SECURE Phase III Study At The Conference March 16, 2017 FDA Grants Merck's Keytruda Priority Review for Cervical Cancer March 12, 2018 4 Possible Biotech Takeover Targets for 2018 December 11, 2017
Agile Therapeutics, Inc. Announces A Poster Presentation Of Its SECURE Phase III Study At The Conference March 16, 2017